KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Times Interest Earned: 2010-2025

Historic Times Interest Earned for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Sep 2025 value amounting to $15.01.

  • Rigel Pharmaceuticals' Times Interest Earned rose 119.91% to $15.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.70, marking a year-over-year increase of 1200.30%. This contributed to the annual value of $3.06 for FY2024, which is 202.47% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Times Interest Earned stood at $15.01 for Q3 2025, which was down 53.98% from $32.61 recorded in Q2 2025.
  • Rigel Pharmaceuticals' Times Interest Earned's 5-year high stood at $86.09 during Q1 2021, with a 5-year trough of -$22.79 in Q2 2022.
  • Moreover, its 3-year median value for Times Interest Earned was $1.03 (2023), whereas its average is $4.69.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Times Interest Earned slumped by 207.17% in 2022 and then spiked by 14,700.20% in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Times Interest Earned (Quarterly) stood at -$16.49 in 2021, then surged by 111.39% to $1.88 in 2022, then crashed by 45.11% to $1.03 in 2023, then spiked by 726.35% to $8.52 in 2024, then surged by 119.91% to $15.01 in 2025.
  • Its Times Interest Earned was $15.01 in Q3 2025, compared to $32.61 in Q2 2025 and $6.89 in Q1 2025.